DEANNA WINTER: Open Payments
NPI 1043268170 · EDGEWOOD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 40 payments from 15 companies in 2025. Trend: 2023 $199 · 2024 $668 · 2025 $895
Food & beverage: $895
| Company | Payments | Amount |
|---|---|---|
| Biosense Webster, Inc. | 1 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $144 |
| Boston Scientific Corporation | 1 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $128 |
| PFIZER INC. | 5 | $84 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Octapharma USA, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $24 |
Products named: CARTO 3, Kerendia, WATCHMAN Access System, JARDIANCE, ELIQUIS, FARXIGA, CAMZYOS, VYNDAQEL.
Industry payments across KY — which companies pay providers there.
